Heart Failure Drugs Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Heart Failure Drugs Market estimated at US$5 Billion in the year 2020, is projected to reach a revised size of US$11.3 Billion by 2028, growing at a CAGR of 12% over the forecast period 2022-2028.

Heart failure refers to a complex clinical syndrome with specific signs and symptoms due to structural and functional cardiac abnormalities. Treatment of this syndrome relies on angiotensin-converting enzyme inhibitors, angiotensin receptor II blockers, beta blockers, and diuretics. Heart failure medications, such as ACE inhibitors, work in different ways in case of heart attack to prevent the formation of geotensin, which constricts blood vessels, geotensin helps lower the effect of geotensin on the heart, and beta-blockers contain certain chemicals.

Market Segments

By Type

• Beta-Blockers
• ACE Inhibitors
• Angiotensin-Receptor Neprilysin Inhibitors (ARNI)
• Angiotensin Receptor Blockers (ARBs)
• Diuretic
• Others

By End-User

• Hospitals
• Specialty Centers

Key Players

• Amgen Inc. (U.S.),
• AstraZeneca (U.K.),
• Novartis AG (Switzerland),
• Boehringer Ingelheim International GmbH (Germany),
• Johnson & Johnson Services, Inc. (U.K.),
• Bristol-Myers Squibb Company (U.S.),
• Merck Sharp & Dohme Corp. (U.S.),
• Pfizer, Inc. (U.S.),
• Gilead Sciences, Inc. (California)

Scope of the Report

The research study analyzes the global Heart Failure Drugs industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Heart Failure Drugs Market Report

1. What was the Heart Failure Drugs Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Heart Failure Drugs Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Heart Failure Drugs Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.